| View |
|
DRP-12330
|
Loratadine
|
Sylergy
|
5 mg
|
Chewable Tablet
|
Antihistamine
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
18 July 2022
|
18 July 2027
|
| View |
|
DRP-12329
|
Loratadine
|
Sylergy
|
10 mg
|
Chewable Tablet
|
Antihistamine
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
18 July 2022
|
18 July 2027
|
| View |
|
DRP-4184-08
|
Paracetamol
|
Ztam
|
500mg
|
Tablet
|
Analgesic/ Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
25 January 2023
|
08 January 2028
|
| View |
|
DRP-10021-04
|
Multivitamins
|
None
|
Each Tablet contains: Ascorbic Acid (Vitamin C) Thiamine Mononitrate (Vitamin B1) Nicotinamide (Vitamin B3) Riboflavin (Vitamin B2) Calcium Pantothenate (Vitamin B5) Pyridoxine Hydrochloride (Vitamin B6) Cyanocobalamin (Vitamin B12)
500 mg 50 mg 50 mg 20 mg 20 mg 5 mg 5 mcg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (CLIDP)
|
15 July 2022
|
09 July 2026
|
| View |
|
DRP-3836-10
|
Betahistine Hydrochloride
|
Cassavert
|
16 mg
|
Film-Coated Tablet
|
Anti-Vertigo
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Initial [CLIDP]
|
26 July 2022
|
09 December 2025
|
| View |
|
DRP-12368
|
Metoprolol Tartrate
|
Docmet
|
50 mg
|
Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
26 July 2022
|
26 July 2027
|
| View |
|
DRP-12381
|
Metoprolol Tartrate
|
Golmet
|
50 mg
|
Tablet
|
Selective Beta-Blocking Agent
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
28 July 2022
|
28 July 2027
|
| View |
|
DRP-12331
|
Vinorelbine (as Tartrate)
|
Prorelbine
|
10 mg/ mL (50mg/5mL)
|
Solution For Injection (IV)
|
Antineoplastic Agent (Vinca alkaloid and analogue)
|
Jiangsu Hansoh Pharmaceutical Co., Ltd.
|
China
|
Initial
|
19 July 2022
|
19 July 2027
|
| View |
|
DRP-1794-03
|
Mefenamic Acid
|
Mefic
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial [CLIDP)
|
26 July 2022
|
14 November 2025
|
| View |
|
DRP-4263-02
|
Paracetamol
|
Gesictab
|
500mg
|
Tablet
|
Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
21 March 2023
|
26 February 2028
|
| View |
|
DRP-5421-07
|
Telmisartan
|
Vas8
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab (Unit II)
|
India
|
Renewal
|
01 July 2024
|
05 August 2029
|
| View |
|
DRP-4985-06
|
Oxytocin
|
Goxy Inj
|
10 IU/mL
|
Solution for Injection (I.M./I.V./S.C.)
|
Posterior Pituitary Hormone
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
21 June 2023
|
11 December 2028
|
| View |
DRP-12332_PI_01.pdf
|
DRP-12332
|
Losartan Potassiumn
|
Rigidon
|
50 mg
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
San Marino Laboratories Corporation
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
| View |
|
DR-XY48230
|
Topiramate
|
Trokendi XR
|
50 mg
|
Extended Release Capsule
|
Antiepileptic
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
26 July 2022
|
26 July 2025
|
| View |
|
DR-XY48231
|
Topiramate
|
Trokendi XR
|
50 mg
|
Extended Release Capsule
|
Antiepileptic
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
27 July 2022
|
27 July 2025
|
| View |
|
DRP-8655-05
|
Nicardipine Hydrochloride
|
Enipidracin
|
1 mg/mL (10 mg / 10 mL)
|
Solution for I.V. Infusion
|
Antihypertensive (Calcium Channel Blocker)
|
Fabre Firma
|
India
|
Initial (CLIDP)
|
27 July 2022
|
23 April 2025
|
| View |
|
DRP-1926-04
|
Phenylpropanolamine Hydrochloride + Brompheniramine Maleate
|
SinuCare
|
6.25mg/2mg per mL
|
Syrup (Oral Drops)
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
02 July 2024
|
21 May 2029
|
| View |
|
DRP-10249-02
|
Levofloxacin (As Hemihydrate)
|
Genfloxin
|
500mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolones)
|
Sozin Flora Pharma LLP
|
India
|
Initial [CLIDP]
|
26 July 2022
|
20 August 2026
|
| View |
|
DRP-3536-06
|
Amlodipine (As Besilate)
|
TG Amlomax
|
5 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Initial [CLIDP)
|
26 July 2022
|
11 April 2026
|
| View |
|
DRP-7834-01
|
Metoclopramide (As Hydrochloride)
|
Metzil
|
5 mg/mL (10 mg/2 mL)
|
Solution for Injection (I.M./I.V. Infusion)
|
-
|
Yung Shin Pharmaceutical Ind. Co., Ltd. (Taichung Youth
Factory)
|
Taiwan
|
Initial [CLIDP]
|
26 July 2022
|
19 February 2026
|